On Demand 2017 Demystifying MCAS (MOC)
Price: $25 members, $35 non-members
You can earn up to 1.75 AMA PRA Category 1 Credits™, and up to 1.75 MOC Part II Self-Assessment credits.
There remains extensive debate regarding the definition of mastocytosis and MCAS. This session will clarify the diagnostic criteria and outline treatment possibilities.
- History and Associated Diseases
- Laboratory Evaluation: Develop a Diagnostic Treatment Plan
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Of the AMA PRA Category 1 Credits™ listed above, the ABAI has designated a maximum of 1.75 credits as meeting the requirements for MOC Part II Self-Assessment.
Medical professionals who treat patients with allergic and/or immunological conditions:
- Practicing allergist/immunologists
- Allergy/immunology Fellows-in-Training
- Physician assistants
- Nurses and advanced practice nurses
- Allied health professionals
- Primary care physicians
- Other medical professionals
- Illustrate the appropriate historical and physical manifestations of chronic sinusitis and accompanying comorbidities.
- Design the appropriate laboratory evaluation to confirm the diagnosis of mastocytosis from mast cell activation syndrome.
- Evaluate treatment options for MCAS and mastocytosis.
Jay Lieberman, MD, FACAAI
Cem Akin, MD
Lawrence B. Schwartz, MD, FACAAI
Mariana C. Castells, MD, PhD, FACAAI
- 1.75 AMA PRA Category 1 Credit™
- 1.75 Attendance
- 1.75 MOC